























































Log rank p < 0.001 
Fig. 2 























Number at risk 
129 124 110 91 68 45 Low 
129 123 108 89 63 41 Int. 
130 125 115 99 71 45 High 
HR
Int (vs Low) 1.59 0.93 - 2.72
High (vs Low) 1.14 0.65 - 2.01
95%CI
Log rank p = 0.188 
A 



















Number at risk 
54 40 29 23 18 8 
54 43 34 23 17 11 









Int (vs Low) 1.05 0.63 - 1.76
High (vs Low) 0.65 0.37 - 1.15
95%CI





















Number at risk 
43 33 21 18 10 8 
44 38 34 33 28 22 16 








Int (vs Low) 0.38 0.19 - 0.76






















Number at risk 
61 47 40 35 31 21 13 
61 50 45 40 35 24 15 









Int (vs Low) 0.79 0.44 - 1.44
High (vs Low) 0.85 0.48 - 1.52
95%CI















































































2 4 6 8 10 2 4 6 8 10 
HER2+ TN Luminal-low Luminal-high 
































































OR 95% CI p OR 95% CI p
Tumor size 0.83 0.68 - 1.01 0.058 0.78 0.62 - 0.97 0.029
Node status 1.02 0.82 - 1.25 0.888 NE NE NE
Grade 3.44 2.24 - 5.56 < 0.001 1.94 1.22 - 3.23 0.008
Age 0.99 0.97 - 1.01 0.343 NE NE NE
ER+ (vs. ER-) 0.20 0.13 - 0. 30 < 0.001 0.34 0.20 - 0.56 < 0.001
HER2+ (vs. HER2-) 2.49 1.35 - 4.47 0.003 2.18 1.09 - 4.28 0.020
TILs-GS 3.50 2.43 - 5.13 < 0.001 2.02 1.30 - 3.14 0.025
Univariate Multivariate
Table 1 Logistic regression analysis for pCR in the anthracycline and taxane
containing data set*
*pCR: pthological complete response; OR: Odds ratio; CI: Confidence interval; ER:
Estrogen receptor; HER2: Human epidermal growth factor receptor 2.
HR
Int (vs Low) 0.77 0.42 - 1.41
High (vs Low) 0.99 0.56 - 1.78
95%CI



















Number at risk 
189 174 153 113 84 56 
189 182 167 145 127 90 










Int (vs Low) 1.07 0.58 - 1.97
High (vs Low) 0.82 0.42 - 1.60
95%CI



















Number at risk 
71 59 51 36 26 17 
71 66 54 43 33 25 
















































Time (Years) Time (Years) 
U133A Array U133 Plus 2.0 Array 
p = 0.846 p = 0.825 









































































ICOS 34607_at inducible T-cell co-stimulator
SEL1L3 41585_at sel-1 suppressor of lin-12-like 3 (C. elegans)
IL7R 1370_at interleukin 7 receptor
TCF7 32649_at transcription factor 7 (T-cell specific, HMG-box)
CENPA 527_at centromere protein A
IDO1 36804_at indoleamine 2,3-dioxygenase 1
PAPOLA 34855_at poly(A) polymerase alpha
SELL 245_at selectin L
LAMP3 37168_at lysosomal-associated membrane protein 3
CD53 38378_at CD53 molecule
HSPA8 33820_g_at heat shock 70kDa protein 8
MSL3 37974_at male-specific lethal 3 homolog (Drosophila)
CKS2 40690_at CDC28 protein kinase regulatory subunit 2
TTK 572_at TTK protein kinase
LCK 2059_s_at lymphocyte-specific protein tyrosine kinase
WARS 38121_at tryptophanyl-tRNA synthetase
PSME2 41171_at proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
TCP1 34791_at t-complex 1
MCM6 40117_at minichromosome maintenance complex component 6
HLA-DOB 38570_at major histocompatibility complex, class II, DO beta
LCP1 37023_at lymphocyte cytosolic protein 1 (L-plastin)
TXN 36992_at thioredoxin
Supplementary Table 1 Genes differentially overexpressed in IHC-TILs score 2 compared to score 0 (p < 0.001)
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